Sign In
Buy LLY
$1,131.42
+6.04 (+0.537%)
At Close: Jun 05, 2026
Where Will Eli Lilly Be in 5 Years?
04:51am, Friday, 18'th Apr 2025
What a difference five years can make. Just look at Eli Lilly (LLY 14.56%).
Eli Lilly jumps on GLP-1 pill trial success
06:17pm, Thursday, 17'th Apr 2025
CNBC's Angelica Peebles joins 'Fast Money' to talk the latest on oral GLP-1 trials.
Eli Lilly's weight-loss pill: What it means for the sector
05:13pm, Thursday, 17'th Apr 2025
Eli Lilly surged during Thursday's trading session after promising test results came out of the pharmaceutical company's ongoing weight-loss pill trial. Bernstein US biopharmaceuticals senior analyst
Eli Lilly Rallies Over 14%, Notches Best Day Since June 2000 On Oral Weight-Loss Drug Results: Analysts React
04:43pm, Thursday, 17'th Apr 2025
Eli Lilly & Co. LLY shares staged their sharpest single-day rally in nearly 25 years Thursday, after unveiling data from a pivotal trial that could cement its leadership in a weight-loss drug market p
Wall Street Rebounds, Eli Lilly Rallies, UnitedHealth Group Plummets: What's Driving Markets Thursday?
02:05pm, Thursday, 17'th Apr 2025
Wall Street saw a rebound in risk appetite on Thursday ahead of the long Easter weekend, as President Donald Trump signaled positive momentum in trade negotiations.
Eli Lilly: Cementing Its GLP-1 Empire With Orforglipron's Promising Phase 3 Results
01:45pm, Thursday, 17'th Apr 2025
Eli Lilly's oral GLP-1 drug orforglipron showed strong Phase 3 results with 7.9% weight loss and good tolerability, establishing leadership in obesity treatment. Orforglipron offers advantages over co
Top Stock Movers Now: UnitedHealth, Nvidia, Eli Lilly and More
01:11pm, Thursday, 17'th Apr 2025
The major U.S. equities indexes were mixed at midday Thursday, with the Dow Jones Industrial Average down close to 400 points as UnitedHealth Group (UNH) shares plunged. The tech-heavy Nasdaq and the
Lilly's Diabetes Pill Clears Major Trial, Analyst Points To Global Potential
12:58pm, Thursday, 17'th Apr 2025
Eli Lilly And Co LLY on Thursday reported topline Phase 3 results from ACHIEVE-1 trial of orforglipron compared to placebo in adults with type 2 diabetes and inadequate glycemic control with diet a
Here's Why Eli Lilly (NYSE: LLY). Fidelity National (NYSE: FIS) and Diamondback Energy (Nasdaq: FANG) Are Soaring Today
12:58pm, Thursday, 17'th Apr 2025
The Dow Jones Industrial Average is tumbling by another 440 points in midday trading today, as President Trump criticized Federal Reserve chairman Jerome Powell's position, but the fact he is not tryi
Why Eli Lilly Stock Is Soaring Today, While Novo Nordisk and Viking Therapeutics Slide
12:46pm, Thursday, 17'th Apr 2025
It's Thursday morning, 11:50 a.m. ET -- and Eli Lilly (LLY 15.96%) stock is off to the races!
Eli Lilly stock surges 15% after clinical trial of weight loss pill shows it works like Ozempic
12:11pm, Thursday, 17'th Apr 2025
The mid-stage trial results announced by the pharmaceutical giant showed that patients taking orforglipron lost an average of 16 pounds.
Eli Lilly Stock Surges on Weight-Loss Drug Trial Success
11:10am, Thursday, 17'th Apr 2025
Eli Lilly & Co (NYSE:LLY) stock is headed for its best day since August 2023, last seen up 13.4% at $838.48 at last check, after the pharmaceutical giant reported positive results for a phase 3 tri
LLY Gains on Weight Loss Pill, AXP Mixed Earnings, DHI Weakness Continues
10:35am, Thursday, 17'th Apr 2025
Eli Lilly (LLY) rallied after it posted positive trial results for its latest weight loss drug. American Express (AXP) had a mixed earnings report but assured Americans are "eating out and enjoying li
Lilly reports positive phase 3 trial results for GLP-1 pill
10:29am, Thursday, 17'th Apr 2025
CNBC's Angelica Peebles joins 'Squawk on the Street' to discuss the latest results from Eli Lilly's efforts to develop a GLP-1 pill.
These 2 Dividend Giants Are at 52-Week Lows. Time to Buy?
10:08am, Thursday, 17'th Apr 2025
One man's trash may be another man's treasure, but dumpster diving when investing carries risks.
